Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1.u1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 112,809 $ 235,311
Accounts receivable, net of allowance of $0 and $0 as of December 31, 2023 and 2022. 45,000
Total Current Assets 220,721 429,119
Total Assets 220,721 429,119
Current Liabilities    
Accounts payable and accrued expenses 1,381,849 1,220,017
Total Current Liabilities 4,763,604 4,110,276
Long Term Liabilities    
Convertible note payable, net of debt discount of $ 19,845 as of December 31, 2022 480,155
Total Long Term Liabilities 480,155
Total Liabilities 4,763,604 4,590,431
Commitments and Contingencies (Note 8)
Stockholders’ Deficit    
Preferred stock, $0.0001 par value, 50,000,000 shares authorized, none issued and outstanding as of December 31, 2023, and December 31, 2022
Common stock, $0.0001 par value: authorized 500,000,000, 21,674,000 and 21,674,000 shares issued and outstanding as of December 31, 2023, and December 31, 2022, respectively 2,167 2,167
Additional paid-in capital 810,048 810,048
Accumulated deficit (5,355,098) (4,973,527)
Stockholders’ Deficit (4,542,883) (4,161,312)
Total Stockholders’ Deficit (4,542,883) (4,161,312)
Total Liabilities and Stockholders’ Deficit 220,721 429,119
Related Party [Member]    
Current Assets    
Investment at fair value - related party 107,912 148,808
Current Liabilities    
Accounts payable - related party 911,659 911,659
Short -term advances - related party 1,673,558 1,673,558
Convertible note payable 25,000 25,000
Convertible note payable 173,192 173,192
Notes payable - related party 106,850 106,850
Nonrelated Party [Member]    
Current Assets    
Investment at fair value - related party 0  
Current Liabilities    
Convertible note payable $ 491,496